About us
Services & Solutions
Chemistry DMPK Discovery Biology Oncology Pharmacology Biologics
Medicinal Chemistry Computational Chemistry Synthetic Chemistry Analytical Chemistry Scale Up Chemistry
In Vivo PK and TK In Vitro ADME Bioanalytical Service Exploratory Toxicity In Rodents, Dogs and Monkeys Large Molecules Capabilities Bioanalytical Instruments
Biochemical Assays Cellular Assays Protein Science Assay Technologies Biophysics SPR Safety Pharmacology Screening Services Key Instruments
PDX CDX Orthotopic Models Syngeneic Models Humanized Mouse Models CAR-T and CAR-NK Mouse Models In Vitro Assays
Immunology Inflammation Metabolic NASH Respiratory Neuroscience
Systematic Antibody Discovery Service
Process R&D Scale Up Synthesis DS Manufacturing
Flow Chemistry Sugar Chemistry Peptide Chemistry Preparative Purification Capacity Process Safety Assessment
Synthetic and Scale Up Chemistry Parallel Synthesis
Flow Chemistry Pilot plant QA EHS
Pre-Formulation Formulation, Analytical and Process Development Drug Product Manufacturing
Bioavailability Enhancement Modified Release
Commercial Manufacturing
Platforms
News & Resources
Careers
Contact us
CN EN
×
news
Company News Events Insights Webinars
BioDuro-Sundia Wins Life Sciences Review Top 10 BPO Award
Irvine, CA, April 3, 2023 – Life Sciences Review magazine recognizes BioDuro-Sundia as top 10 Business Process Outsourcing (BPO). BioDuro-Sundia earned this award for its high-quality serv
April 03, 2023
BioDuro-Sundia Announces Formation of Scientific Advisory Board
Irvine, CA, March 27, 2023 – BioDuro-Sundia announced today the establishment of a Discovery Research Scientific Advisory Board (SAB) with the appointment of Andrew Thomas Ph.D. and Zach Sweeney Ph.D. as its members. The SAB will advise BioDuro-Sundia as the company is growing its discovery capabilities and capacities.
March 27, 2023
BioDuro-Sundia Forms Strategic Partnership with Kanwhish
Shanghai, March 30, 2023 – To promote a long-term mutually beneficial strategic partnership, BioDuro-Sundia recently signed a strategic cooperation agreement with Suzhou Kanwhish Biotechnology Co., Ltd.BioDuro-Sundia is the ind
March 20, 2023
BioDuro-Sundia Expands Drug Discovery Capacity and Capability
Shanghai, February 13, 2023 – BioDuro-Sundia has recently completed Discovery capability expansions of more than 100K ft2 of laboratory space within three different R&D Centers (Shanghai Waigaoqia
February 13, 2023
Congratulations to NanoRay Biotech for its anticancer therapy approved by the US FDA for Clinical Trial
Shanghai, September 29, 2022 – Congratulations to NanoRay Biotech Co., Ltd.’s [Auger Molecular Therapy], which has been approved by the US FDA for Clinical Trial.
September 29, 2022
Total 78 12345678...1516
Subscribe to BioDuro-Sundia
Receive our newsletter and information on upcoming events
Your trusted partner from drug discovery and
development to commercialization

Home

About us

Services & Solutions

Platforms

News & Resources

Careers

Contact us

Explore

Discovery

Drug Substance

Drug Product

© 2023 BioDuro-Sundia. All rights reserved
Terms of Use Privacy Policy
We use necessary cookies to ensure our website functions properly and to keep it secure. These necessary cookies must be enabled. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You can personalize or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third parties intervening on our website, please consult the Privacy Notice available in the site footer.
Accept all